LeLaf

VTGN: Ascending Triangle (71%), Bullish Pennant (136%)

Long
NASDAQ:VTGN   VistaGen Therapeutics, Inc
Primary Target (short term):
Ascending Triangle (71%)
PT = 4.39$

Secondary Target (Long term):
Bullish Pennant , confirmed (136%)
PT = 4.61$